Radioligand binding characterization of the bradykinin B2 receptor in the rabbit and pig ileal smooth muscle

European Journal of Pharmacology

Volumn 635, Issue 1-3, 2010, Pages 34-39

  Meini, Stefania ^a   Cucchi, Paola ^a   Catalani, Claudio ^a   Bellucci, Francesca ^a   Santicioli, Paolo ^a   Giuliani, Sandro ^a   Maggi, Carlo Alberto ^a  

^a Menarini Ricerche SpA   (Italy)

Author keywords

FR173657; Icatibant; LF16 0687; MEN16132; WIN64338

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; 4 AMINO [5 [4 [4 [2,4 DICHLORO 3 (2,4 DIMETHYL 8 QUINOLYLOXYMETHYL)PHENYLSULFONAMIDO]TETRAHYDRO 2H 4 PYRANYLCARBONYL]PIPERAZINO] 5 OXOPENTYL](TRIMETHYL)AMMONIUM CHLORIDE; [[4 [2 [[BIS(CYCLOHEXYLAMINO)METHYLENE]AMINO] 3 (2 NAPHTHYL)PROPIONAMIDO]PHENYL]METHYL]TRIBUTYLPHOSPHONIUM CHLORIDE; ANATIBANT; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; MEN 11270; MEN 16132; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; INTESTINE MUSCLE; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPECIES DIFFERENCE; SWINE;

ANIMALS; BRADYKININ; CELL MEMBRANE; FEMALE; GUINEA PIGS; HUMANS; ILEUM; LIGANDS; MALE; MICE; MUSCLE, SMOOTH; ORNITHINE; PROTEIN BINDING; RABBITS; RECEPTOR, BRADYKININ B2; SUBSTRATE SPECIFICITY; SULFONAMIDES; SWINE;

EID: 77952322087     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.03.012     Document Type: Article

References (44)

1. Aramori I., Zenkoh J., Morikawa N., O'Donnell N., Asano M., Nakamura K., Iwami M., Kojo H., Notsu Y. Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657. Mol. Pharmacol. 1997, 51:171-176.
2. 2 receptor. J. Pharmacol. Exp. Ther. 1995, 275:1623-1630.
3. Bellucci F., Cucchi P., Santicioli P., Lazzeri M., Turini D., Meini S. Characterization of kinin receptors in human cultured detrusor smooth muscle cells. Br. J. Pharmacol. 2007, 150:192-199.
4. 2 receptor antagonism in human synovial fibroblasts. Br. J. Pharmacol. 2009, 158:1996-2004.
5. 2 receptor ligands. Can. J. Physiol. Pharmacol. 2002, 80:281-286.
6. 50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22:3099-3108.
7. 2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats. J. Pharmacol. Exp. Ther. 2009, 331:1025-1032.
8. Couture R., Gaudreau P., St-Pierre S., Regoli D. The dog common carotid artery: a sensitive bioassay for studying vasodilator effects of substance P and of kinins. Can. J. Physiol. Pharmacol. 1980, 58:1234-1244.
9. Couture R., Harrisson M., Vianna R.M., Cloutier F. Kinin receptors in pain and inflammation. Eur. J. Pharmacol. 2001, 429:161-176.
10. Cruden N.L., Newby D.E. Therapeutic potential of icatibant (HOE-140, JE-049). Expert Opin. Pharmacother. 2008, 9:2383-2390.
11. 2 receptor. In vitro pharmacology and molecular characterization. Eur. J. Pharmacol. 2005, 528:7-16.
12. 2 receptor gene. Biochem. Biophys. Res. Commun. 1992, 187:1306-1313.
13. 2 receptor. Eur. J. Pharmacol. 1998, 346:291-298.
14. Gaudreau P., Barabé J., St-Pierre S., Regoli D. Structure-activity study of kinins in vascular smooth muscles. Can. J. Physiol. Pharmacol. 1981, 59:380-389.
15. 2 receptor agonist (FR 190997) and antagonist (FR 173657). Immunopharmacology 1999, 43:179-185.
16. 2 receptors in the rabbit and the guinea pig. Can. J. Physiol. Pharmacol. 1996, 74:137-144.
17. Hall J.M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 1992, 56:131-190.
18. 2 receptor antagonists may be attributable to species. Neuropeptides 1992, 22:28-29.
19. Hock F.J., Wirth K., Albus U., Linz W., Gerhards H.J., Wiemer G., Henke S.T., Breipohl G., König W., Knolle J., Schölkens B.A. Hoe 140 a new potent and long acting bradykinin antagonist: in vitro studies. Br. J. Pharmacol. 1991, 102:769-773.
20. Kimura A., Kihara T., Ohkura R., Ogiwara K., Takahashi T. Localization of bradykinin B(2) receptor in the follicles of porcine ovary and increased expression of matrix metalloproteinase-3 and -20 in cultured granulosa cells by bradykinin treatment. Biol. Reprod. 2001, 65:1462-1470.
21. Laurila J.M., Xhaard H., Ruuskanen J.O., Rantanen M.J., Karlsson H.K., Johnson M.S., Scheinin M. The second extracellular loop of alpha2A-adrenoceptors contributes to the binding of yohimbine analogues. Br. J. Pharmacol. 2007, 151:1293-1304.
22. Leeb-Lundberg L.M., Marceau F., Muller-Esterl W., Pettibone D.J., Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 2005, 57:27-77.
23. 2 receptors on the venoconstrictor action of bradykinin. J. Pharmacol. Exp. Ther. 1994, 269:1136-1143.
24. 2 pharmacological selectivity. Mol. Pharmacol. 1993, 44:346-355.
25. 2 receptor for nonpeptide antagonist ligands recognition. Can. J. Physiol. Pharmacol. 2002, 80:303-309.
26. Meini S., Maggi C.A. Knee osteoarthritis: a role for bradykinin?. Inflamm. Res. 2008, 57:351-361.
27. 2 receptor antagonist MEN16132 in rat in vitro bioassays. Eur. J. Pharmacol. 2009, 615:10-16.
28. 2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists. Biochem. Pharmacol. 2004, 67:601-609.
29. 2 receptor: radioligand binding and smooth muscle contractility studies. Br. J. Pharmacol. 2007, 150:313-320.
30. 2 receptor antagonists in human and rat urinary bladder. Eur. J. Pharmacol. 2000, 388:177-182.
31. 2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum. Eur. J. Pharmacol. 2000, 409:185-194.
32. 2 kinin receptor. J. Pharmacol. Exp. Ther. 1999, 289:1250-1256.
33. Michel A.D., Clay W.C., Ng S.W., Roman S., Thompson K., Condreay J.P., Hall M., Holbrook J., Livermor D., Senger S. Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects. Br. J. Pharmacol. 2008, 155:738-751.
34. 2 receptor antagonist. Immunopharmacology 1999, 43:187-194.
35. 2 subtypes. Life Sci. 1994, 55:735-749.
36. Regoli D., Calo' G., Rizzi A., Bogoni G., Gobeil F., Campobasso C., Mollica G., Beani L. Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors). Regul. Pept. 1996, 65:83-89.
37. 2 kinin receptors in various species. Immunopharmacology 1997, 36:143-147.
38. Regoli D., Rizzi A., Perron S.I., Gobeil F. Classification of kinin receptors. Biol. Chem. 2001, 382:31-35.
39. 2 receptors in pig vessels: characterization of two monoreceptor systems. Naunyn Schmiedebergs Arch. Pharmacol. 1997, 356:662-670.
40. 2 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 1999, 360:361-367.
41. 2 bradykinin receptor stably expressed in CHO-K1 cell line. Br. J. Pharmacol. 2002, 135:462-468.
42. Sawutz D.G., Salvino J.M., Dolle R.E., Seoane P.R., Farmer S.G. Pharmacology and structure-activity relationships of the nonpeptide bradykinin receptor antagonist WIN 64338. Can. J. Physiol. Pharmacol. 1995, 73:805-811.
43. 2 receptor selectively increase efficacy of synthetic ligand HOE 140 but not of cognate ligand bradykinin. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H1924-H1932.
44. 2 receptor antagonist, prevents the endogenous bradykinin effects in guinea-pig airways. Eur. J. Pharmacol. 2008, 579:350-356.